close


發佈日期:2014年2月6日

The management of Type 2 Diabetes (T2D) is complex and challenging.

Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.

Find out more about SGLT2 inhibition and its potential impact on T2D management.

 

arrow
arrow

    changturtle 發表在 痞客邦 留言(0) 人氣()